CD2 MONOCLONAL ANTIBODIES— 510(k) K914846

Substantially Equivalent

Gen Trak, Inc.

FDA 510(k) clearance K914846 for CD2 MONOCLONAL ANTIBODIES, Substantially Equivalent on 1992-06-19. Applicant: Gen Trak, Inc..

Clearance details

Applicant: Gen Trak, Inc.
Product code: Code GKZ
Advisory panel: Hematology
Date received: 1991-10-28
Decision date: 1992-06-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Plymouth Meeting, PA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code GKZ

product code GKZ

Malfunction: 1,205
Total: 1,205

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.